Phase III BEACON-CML

Gilead Sciences · Phase III · Chronic Myeloid Leukemia

92A
Score Breakdown
Protocol Compliance
95
Data Integrity
90
Safety Reporting
88
Site Monitoring
94
IRB/Ethics
96
Informed Consent
91
Gap Findings (2)
Rule IDDescriptionSeverityICH E6 RefDetected
GCP-5.18.4eOne site missing Q4 monitoring visit documentationMAJORICH E6 5.18.4(e)2025-03-01
GCP-8.2.3Investigator CV not updated within 2 years at 2 sitesMINORICH E6 8.2.32025-02-15